Archana Sah is a clinical development thought leader with 27 years of experience and a passion for developing life-saving medicines and products for patients. Having led and contributed to 15 FDA/EMEA drug approvals (12 in Oncology and Immuno-Oncology), Archana is widely recognized as a strategic expert on emerging topics ranging from therapeutic landscape and treatment trends expertise to innovation in clinical excellence. Archana has held leadership roles at Genentech/Roche, Bayer Oncology, Johnson & Johnson, ICON, and two oncology startup companies. At Medable, she heads up Oncology Therapeutic Digital and decentralized clinical trials (DCT) solutions that are designed around the patient to transform oncology drug development.
A leader in driving industry-wide strategic collaborations, Archana is passionate about bringing innovation and efficiencies across the entire clinical trials ecosystem and serves on several collaborations.